Are you Dr. Muler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 69 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5308 Harroun Rd
Suite 055
Sylvania, OH 43560Phone+1 419-824-6599Fax+1 419-885-3870- Is this information wrong?
Summary
- Dr. Jeffrey Muler, MD is an oncologist in Sylvania, Ohio. He is currently licensed to practice medicine in Ohio, Massachusetts, and Virginia. He is affiliated with ProMedica Toledo Hospital, Mercy Health - St. Vincent Medical Center, and St. Luke's Hospital.
Education & Training
University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 2000 - 2003- University of Michigan Health SystemResidency, Internal Medicine, 1996 - 1999
Tufts University School of MedicineClass of 1996
Certifications & Licensure
MA State Medical License 2017 - 2026
OH State Medical License 1999 - 2026
VA State Medical License 1999 - 2026
IN State Medical License 1999 - 2025
MI State Medical License 1999 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer Start of enrollment: 2015 Aug 27
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- A phase II trial of carboplatin, gemcitabine and capecitabine in patients with carcinoma of unknown primary site (CUP).Schneider BJ, Muler J, Philip P, Kalemkerian G, El-Rayes B, Griffith K, Zalupski M> ;J. Clin. Oncol.. 2005-06-01
- 50 citationsAdjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.Mark M. Zalupski, Cathryn Rankin, James R. Ryan, David R. Lucas, Jeffrey Muler, Keith S. Lanier, George Thomas Budd, J. Sybil Biermann, Frederick J. Meyers, Karen H. A...> ;Cancer. 2004 Feb 15
- 73 citationsPhase I Trial Using a Time-to-Event Continual Reassessment Strategy for Dose Escalation of Cisplatin Combined With Gemcitabine and Radiation Therapy in Pancreatic CancerJeffrey H. Muler, Cornelius J. McGinn, Daniel P. Normolle, Theodore Lawrence, Diane Brown, Gwen Hejna, Mark M. Zalupski> ;Journal of Clinical Oncology. 2004 Jan 15
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- ProMedica Defiance Regional HospitalDefiance, Ohio
- Mercy Health - St. Charles HospitalOregon, Ohio
Mercy Health - St. Vincent Medical CenterToledo, Ohio
ProMedica Toledo HospitalToledo, Ohio
St. Luke's HospitalMaumee, Ohio- ProMedica Monroe Regional HospitalMonroe, Michigan
- ProMedica Bixby HospitalAdrian, Michigan
